Results 151 to 160 of about 17,989 (193)
Some of the next articles are maybe not open access.
Management of ANCA associated vasculitis
BMJ, 2020ABSTRACTAnti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis (AAV) is a small to medium vessel vasculitis associated with excess morbidity and mortality. This review explores how management of AAV has evolved over the past two decades with pivotal randomized controlled trials shaping the management of induction and maintenance of remission.
Zachary S, Wallace, Eli M, Miloslavsky
openaire +2 more sources
Biomarkers in ANCA-Associated Vasculitis
Current Rheumatology Reports, 2013Despite recent advances in the treatment of antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (AAV), relapse remains common and patients often experience a variable clinical course after initial treatment. New biomarkers are needed to aid the management of these complex diseases.
Lindsay, Lally, Robert F, Spiera
openaire +2 more sources
2009
The majority of patients with Wegener's granulomatosis (WG) or microscopic polyangiitis (MPA) have antineu-trophil cytoplasmic antibodies (ANCA) in their serum. This is particularly true of patients with "disseminated" disease, the great majority of whom are ANCA positive.
Stone, John H. +7 more
openaire +1 more source
The majority of patients with Wegener's granulomatosis (WG) or microscopic polyangiitis (MPA) have antineu-trophil cytoplasmic antibodies (ANCA) in their serum. This is particularly true of patients with "disseminated" disease, the great majority of whom are ANCA positive.
Stone, John H. +7 more
openaire +1 more source
Pathophysiology of ANCA-associated Vasculitis
Advances in Anatomic Pathology, 2017Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis is characterized as inflammation of small-sized to medium-sized blood vessels and encompasses several clinicopathologic entities including granulomatosis with polyangiitis, microscopic polyangiitis, eosinophilic granulomatosis with polyangiitis, and renal-limited ANCA-associated ...
Turki, Al-Hussain +4 more
openaire +2 more sources
Rituximab in ANCA-Associated Vasculitis
Current Rheumatology Reports, 2017The purpose of this review is to describe the efficacy and safety of rituximab (RTX) as a remission induction and maintenance therapy in ANCA-associated vasculitis (AAV).A PubMed search was carried out to track down articles published between February 2006 and February 2016.
Romina I, Hassan, Angelo L, Gaffo
openaire +2 more sources
Treatment of ANCA-associated vasculitis
Nature Reviews Nephrology, 2013Antineutrophil cytoplasmic autoantibody (ANCA)-associated diseases are small-vessel vasculitides, encompassing granulomatosis with polyangiitis (formerly Wegener's granulomatosis), microscopic polyangiitis and eosinophilic granulomatosis with polyangiitis.
Ulf, Schönermarck +2 more
openaire +2 more sources
Advances in Kidney Disease and Health
ANCA-associated vasculitis (AAV) is a necrotizing, small-to-medium vessel vasculitis associated with significant morbidity and mortality. AAV is a systemic autoimmune disease affecting kidneys, eyes, sinuses, peripheral nerves, skin, and upper and lower respiratory tracts.
Purva Sharma, Reza Zonozi, Duvuru Geetha
openaire +2 more sources
ANCA-associated vasculitis (AAV) is a necrotizing, small-to-medium vessel vasculitis associated with significant morbidity and mortality. AAV is a systemic autoimmune disease affecting kidneys, eyes, sinuses, peripheral nerves, skin, and upper and lower respiratory tracts.
Purva Sharma, Reza Zonozi, Duvuru Geetha
openaire +2 more sources
Epidemiology of ANCA-associated Vasculitis
Rheumatic Disease Clinics of North America, 2010The epidemiology of the antineutrophil cytoplasm antibody (ANCA)-associated vasculitides (AAV), comprising Wegener's granulomatosis, microscopic polyangiitis, and Churg-Strauss syndrome, poses considerable challenges to epidemiologists. These challenges include the difficulty of defining a case with a lack of clear distinction between the different ...
Ntatsaki, Eleana +2 more
openaire +3 more sources
Pathogenesis of ANCA-Associated Vasculitis
Current Rheumatology Reports, 2012Antineutrophil cytoplasmic autoantibodies (ANCA)-associated vasculitides (AAV) are a group of systemic vasculitis syndromes characterized by inflammation and necrosis of blood vessel walls. Genetic, epigenetic, and environmental factors contribute to the etiology and pathogenesis of AAV.
Rodrigo, Cartin-Ceba +2 more
openaire +2 more sources